Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

Clinicians and researchers continue to push back on unsupported claims about the causes of autism while new NIH projects aim ...

This finding contradicts some recent studies indicating the number of people with cardiovascular disease who did not have any ...

Combining an antiplatelet with oral anticoagulants in stroke patients with AF and cardiovascular disease slightly lowers ...

Ultrasound demonstrated a strong correlation and agreement with CT in assessing the diameter of the ascending aorta in patients with giant cell arteritis (GCA), supporting its use as an effective ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...

Novel AI tools can help flag acute kidney injury, stratify chronic kidney disease risk, and speed drug discovery, but experts ...

Hello. It's Mark Kris from Memorial Sloan Kettering. Recently, I presented information about the published trials of neoadjuvant nivolumab chemotherapy vs chemotherapy, showing robust, disease-free ...

Almost three-quarters of UK GPs say workload pressures are putting patient safety at risk, according to a new Royal College of General Practitioners (RCGP) survey. The college’s annual GP Voice survey ...

An AI tool can detect tiny brain lesions causing drug-resistant epilepsy in children with up to 94% accuracy, potentially ...

Five-year cancer survival rises in US states that expanded Medicaid, specifically in rural and high poverty communities.

Taliban restrictions, aid cuts, and the August 31 earthquake have left Afghan women without lifesaving care, exposing a ...